Using vaginal estrogen tablets was not associated with an increased risk of recurrent ischemic stroke among postmenopausal women in a registry in Denmark, according to research published in Stroke.

Stroke survivors often face tough choices about managing menopause symptoms. A new study from Copenhagen University Hospital–Herlev and Gentofte found that vaginal estrogen tablets were not linked to ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

Hormone replacement therapy can help ease the symptoms of menopause. Learn more about the risks and benefits.

Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

Exposure to vaginal estradiol not linked to increased rate of recurrent ischemic stroke when adjusted for comorbidity, medications, income, education. (HealthDay News) — For women with a history of ...

Women with breast cancer who use vaginal estrogen therapies, such as tablets or creams, do not face an increased risk for breast cancer–specific mortality, which can provide some reassurance to ...

Hormone replacement therapy using vaginal estrogen tablets was not associated with an increased risk of ischemic stroke for postmenopausal women who have already had a stroke, according to a data ...